We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

MedinCell and Corbion Form CM Biomaterials

News   Aug 12, 2015

 
MedinCell and Corbion Form CM Biomaterials
 
 
Advertisement
 

RELATED ARTICLES

Starving Brain Tumor Cells To Treat Medulloblastoma

News

Preclinical research using human tissue samples, human cell lines and mice has revealed that inositol hexaphosphate (IP6), a naturally occurring compound, inhibits medulloblastoma and can be combined with chemotherapy to kill tumor cells.

READ MORE

Adhesive Patch Delivers Blood Vessel-Forming Factors to Damaged Tissues

News

A research team has bioengineered a novel adhesive patch platform that can efficiently deliver blood vessel-forming growth factors using a bio-adhesive material that is made from mussels harmless to humans.

READ MORE

Personalized Cancer Vaccine Shows Early Efficacy in Patients With Diverse Tumor Types

News

Treatment with the neoantigen cancer vaccine PGV-001 following standard-of-care adjuvant therapy was well tolerated and demonstrated potential clinical benefit in patients with diverse tumor types according to a Phase 1 study. The findings were reported during the virtual AACR Annual Meeting 2021.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE